BIOMAT Database Logo BIOMAT Database Logo

[Non-nucleoside reverse transcriptase inhibitors. AIDS long-term management]. 1998

R Sautter

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

R Sautter
[Non-nucleoside reverse transcriptase inhibitors].
June 2000, Annales de medecine interne,
R Sautter
Non-nucleoside reverse transcriptase inhibitors.
June 1996, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation,
R Sautter
Lipodystrophy and long-term therapy with nucleoside reverse transcriptase inhibitors.
May 2000, AIDS (London, England),
R Sautter
Non-nucleoside reverse transcriptase inhibitors: a review.
January 2007, International journal of clinical practice,
R Sautter
Non-nucleoside reverse transcriptase inhibitors--an overview.
February 2003, International journal of STD & AIDS,
R Sautter
[Resistance to non-nucleoside reverse transcriptase inhibitors].
February 2001, Enfermedades infecciosas y microbiologia clinica,
R Sautter
Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
January 2005, Antiviral therapy,
R Sautter
New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
June 2008, Journal of HIV therapy,
R Sautter
Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.
November 1999, Antiviral chemistry & chemotherapy,
R Sautter
[Non-nucleoside reverse transcriptase inhibitors. First line therapy].
January 2000, MMW Fortschritte der Medizin,
Copied contents to your clipboard!